US HB5314 | 2015-2016 | 114th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on May 24 2016 - 25% progression, died in committee
Action: 2016-05-24 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 24 2016 - 25% progression, died in committee
Action: 2016-05-24 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Empowering Pharmacists in the Fight Against Opioid Abuse Act This bill requires the Drug Enforcement Administration (DEA) to develop and disseminate training programs and materials on: (1) the circumstances under which a pharmacist may refuse to fill a controlled substance prescription suspected to be fraudulent, forged, or indicative of abuse or diversion; and (2) federal requirements related to such refusal. The DEA must seek input from relevant stakeholders.
Title
Empowering Pharmacists in the Fight Against Opioid Abuse Act
Sponsors
Rep. Mark DeSaulnier [D-CA] | Rep. Earl Carter [R-GA] |
History
Date | Chamber | Action |
---|---|---|
2016-05-24 | House | Referred to the House Committee on Energy and Commerce. |
2016-05-24 | House | Introduced in House |
Subjects
Crime and law enforcement
Drug trafficking and controlled substances
Fraud offenses and financial crimes
Government information and archives
Health promotion and preventive care
Prescription drugs
Drug trafficking and controlled substances
Fraud offenses and financial crimes
Government information and archives
Health promotion and preventive care
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/114th-congress/house-bill/5314/all-info |
Text | https://www.congress.gov/114/bills/hr5314/BILLS-114hr5314ih.pdf |